Back to the main directory
EarningsReview / Equity
- Solid start to the year by BNP Paribas Exane
- Reassuring by BNP Paribas Exane
- Fabege - A write-down burdened the quarterly results by Danske Bank Equity Research
- Fabege - Hold: More questions than answers by Nordea
- INVEST SECURITIES - RENAULT : Une Alliance enfin ajustée pour mieux coopérer - ACHAT, OC 54€ by Invest Securities
- Numis Corporation - Revenues running in line with H222 by Edison Investment Research
- Ebiquity - Strong revenue growth and improving margin by Edison Investment Research
- Filtronic - Component shortages causing delivery delays by Edison Investment Research
- LINDE: RDOS. 4T’22 (ANÁLISIS BANCO SABADELL) by Sabadell
- Another guidance cut after a soft Q3 by BNP Paribas Exane
- Vection Technologies - Space travel in the metaverse by Edison Investment Research
- The trend is not your friend by BNP Paribas Exane
- China: Time to buckle up by BNP Paribas Exane
- Paradox Interactive - Strong beat, but 2023 now looks fully priced by Danske Bank Equity Research
- FY22 results and 15 questions for management by BNP Paribas Exane
- Fabege (Hold, TP: SEK100.00) - High indexation removing ‘cushion’ by DnB Markets
- Höegh Autoliners ASA (Buy, TP: NOK93.00) - Shifting into high gear by DnB Markets
- DNO (Buy, TP: NOK16.00) - Minor model adjustment by DnB Markets
- Vow (Buy, TP: NOK22.00) - Waiting for large contracts by DnB Markets
- Metsa Board (Buy, TP: EUR12.00) - Outlook still rosy by DnB Markets
- Sandvik (Buy, TP: SEK260.00) - Material upside to SMM for 2023e by DnB Markets
- Vimian (Buy, TP: SEK43.00) - Facing another challenging quarter by DnB Markets
- Paradox Interactive AB (Hold, TP: SEK220.00) - Improved cost control paying off by DnB Markets
- Embracer Group (Buy, TP: SEK100.00) - Slight cash-flow improvement likely by DnB Markets
- Hutchison Port Holding (HPHT SP) by HSBC
- 50 questions into the Investor Day by BNP Paribas Exane
- Resiliency, On Sale by BNP Paribas Exane
- BioArctic - Buy/SEK 356: Timelines shifting in favour of BioArctic by Nordea
- Investment Daily 07/02/2023 by BNP Paribas Exane
- Respiri - Dollars in the bank with CMS reimbursement by Edison Investment Research
- BNP PARIBAS: RDOS. 4T'22 (ANÁLISIS BANCO SABADELL) by Sabadell
- 中青旅（600138 CH） by HSBC
- Strong Q4 22, further growth ahead by BNP Paribas Exane
- Margins remain an uncertainty by BNP Paribas Exane
- Novatek Microelectronics (3034 TT) by HSBC
- China: Open Season by BNP Paribas Exane
- Chinese disruption at a discount by BNP Paribas Exane
- China reopening play... and a lot more by BNP Paribas Exane
- Strategic focus areas build on strong quarter by BNP Paribas Exane
- Demant (Buy, TP: DKK240.00) - Strong 2023 guidance by DnB Markets
- Telenor (Buy, TP: NOK155.00) - Conviction reinforced by DnB Markets
- Wallenius Wilhelmsen ASA (Buy, TP: NOK131.00) - More fuel in the tank by DnB Markets
- Camurus (Buy, TP: SEK320.00) - Continued sales growth expected by DnB Markets
- The Kingfish Company (Hold, TP: NOK12.40) - New money and a new CEO by DnB Markets
- Shelf Drilling North Sea (Buy, TP: NOK45.00) - Overlooked by DnB Markets
- Resurs Holding (Hold, TP: SEK25.00) - MiNIMal rate-hike benefits by DnB Markets
- Lundbeck (Buy, TP: DKK39.00) - Ambitious medium-term targets by DnB Markets
- Demant (Buy, TP: DKK275.00) - Oticon Real to support 2023 growth by DnB Markets
- Record lows straight ahead by DnB Markets
- BP cutting oil & gas production at a slower pace by DnB Markets